Jaya Therattil
Allergy · Augusta, GANPI 1043285810
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.3% of the total across 189 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 28 manufacturers reported payments, led by GSK at 31.2% of the total. Reporting peaked in 2019 at $1,237 and has fallen 64.7% since, to $437 in 2025.
Across 189 payments — averaging $21.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$1K
- AstraZeneca$995
- Jazz Pharmaceuticals Inc.$298
- Regeneron Healthcare Solutions, Inc.$199
- Sunovion Pharmaceuticals Inc.$152
- Harmony Biosciences LLC$120
- plus $994 from 22 others
What the payments were for
- Food & beverage$3,94098%
- Education$702%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 60 | $1,252 |
| AstraZeneca | 36 | $995 |
| Jazz Pharmaceuticals Inc. | 11 | $298 |
| Regeneron Healthcare Solutions, Inc. | 8 | $199 |
| Sunovion Pharmaceuticals Inc. | 11 | $152 |
| Harmony Biosciences LLC | 5 | $120 |
| Grifols USA, LLC | 5 | $94 |
| Optinose US, Inc. | 6 | $88 |
| Boehringer Ingelheim | 5 | $68 |
| Kaleo, Inc. | 4 | $66 |
| Bayer | 4 | $62 |
| Philips North America LLC | 2 | $61 |
| Merck | 4 | $58 |
| Tetraphase Pharmaceuticals, Inc. | 1 | $55 |
| Actelion Pharmaceuticals US, Inc. | 3 | $53 |
| Advanced Respiratory, Inc | 3 | $42 |
| Nabriva Therapeutics, PLC | 2 | $42 |
| Amgen | 3 | $42 |
| Eisai Inc. | 3 | $37 |
| Novartis | 2 | $37 |
| Mallinckrodt Hospital Products Inc. | 2 | $34 |
| Novo Nordisk | 2 | $32 |
| Teva Pharmaceuticals USA, Inc. | 2 | $27 |
| Insmed, Inc. | 1 | $23 |
| Abbott | 1 | $22 |
| Mylan Specialty L.p. | 1 | $21 |
| Genentech USA, Inc. | 1 | $18 |
| Circassia Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few allergy providers in Georgiato place this figure against a meaningful peer group, so we don't.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Breo ElliptaFluticasone/Vilanterol | 27 | $14,097 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 15 | $7,461 |
| SymbicortBudesonide/Formoterol Fumarate | 14 | $4,462 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 11 | $1,295 |
| Montelukast Sodium | 47 | $531 |
| Fluticasone Propionate | 27 | $347 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKBreo Ellipta, Trelegy Ellipta | $1,252 | $21,55842 claims |
| AstraZenecaSymbicort | $995 | $4,46214 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few allergy providers in Georgiaon file to place this against a meaningful peer group, so we don't.
Other allergy in Augusta
- Donnie DunaganAugusta$19K
- Tesneem ChaudharyAugusta$6K
- Thomas ChackoAlpharetta$63K
- Amy HirshAtlanta$14K
- Tricia LeeDecatur$13K
- Theodore LeeAtlanta$11K
- Anu MongiaCartersville$8K
- John HalwigAustell$5K
- Carol WigginsAtlanta$5K
- Ariana BuchananCarrollton$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.